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the acyl carrier protein (ACP) (McDaniel et al., 1994,University Walk
Bristol, BS8 1TD 1995). The KS catalyzes the decarboxylative condensa-
tion of malonyl extender units, while CLF is involved inUnited Kingdom
2 School of Chemistry formation of acetyl ACP (from the decarboxylation of
malonyl-ACP) (Bisang et al., 1999) and may also influ-University of Bristol
Cantock’s Close ence the chain length of the final polyketide. The growing
polyketide is attached as a thioester via a phosphopan-Bristol BS8 1TS
United Kingdom tetheine group to a serine at the N terminus of helix 2
in ACP. The ACP may have several roles: to sequester
the polyketide chain, protecting it from acid/base enoli-
zation and cyclization, and to act as an extended sub-Summary
strate for the other enzymes in the polyketide synthase.
The molecular details of the interactions between ACPWe have determined the 2.5 A˚ crystal structure of an
active, tetrameric Streptomyces coelicolor type II poly- and the type II enzymes are only just beginning to be
understood (Worsham et al., 2003; Zhang et al., 2001).ketide ketoreductase (actIII) with its bound cofactor,
NADP. This structure shows a Rossman dinucleotide It is evident, however, that in any one biosynthetic path-
way, the ACP has the task of recognizing many differentbinding fold characteristic of SDR enzymes. Of two
subunits in the crystallographic asymmetric unit, one enzymes.
The type II aromatic PKS from Streptomyces coelico-is closed around the active site. Formate is observed in
the open subunit, indicating possible carbonyl binding lor that produces actinorhodin (act) has been exten-
sively studied (Hopwood, 1997). As well as producing asites of the polyketide intermediate. Unlike previous
models we observe crystal contacts that may mimic 16 carbon polyketide chain, the minimal system can
partially control the first cyclization, though productsthe KR-ACP interactions that may drive active site
opening. Based on these observations, we have con- from aberrant cyclizations may also be observed (Fu et
al., 1994a, 1994b). The act minimal PKS produces twostructed a model for ACP and polyketide binding. We
propose that binding of ACP triggers a conformational products, SEK4 (Figure 1) with the correct first cycliza-
tion (C7-C12), and SEK4b with an alternate C10-C15change from the closed to the open, active form of
the enzyme. The polyketide chain enters the active ring closure (Fu et al., 1994b). The act ketoreductase
(act KR) is the first enzyme to modify the polyketide, itssite and reduction occurs. The model also suggests
a general mechanism for ACP recognition which is primary function being to reduce the carbonyl group at
C-9. Addition of the act KR to the minimal system, bothapplicable to a range of protein families.
in vivo and in vitro, yields predominantly mutactin, which
arises from the correctly cyclized and reduced interme-Introduction
diate (Figure 1) (Fu et al., 1994c; Zhang et al., 1990). The
elimination of incorrectly cyclized products suggestsPolyketides are a chemically diverse group of secondary
metabolites produced by bacteria, fungi, plants, and that the KR may aid the minimal complex in directing
the correct aldol condensation between C7 and C12.marine organisms (Hopwood, 1990, 1997; Staunton and
Weissman, 2001). These natural products are of enor- The mechanisms for regiospecific control of cyclization
and reduction are unknown at present. In the presencemous pharmaceutical interest and include antibiotic
of the act KR, there is an overall increase in polyketide(oxytetracycline, a tetracycline), anticancer (doxorubi-
production when compared with the minimal system,cin, an anthracycline), and antifungal (resveratrol, a stil-
possibly suggesting stabilization of the complex or morebene) compounds. Analogous to fatty acid synthases
efficient intermediate channelling (Zawada and Khosla,(FASs) (Smith, 1994), the polyketide synthase (PKS) bio-
1999). The influence of the KR in other minimal systemssynthetic complex is organized as either a covalent (type
has also been reported. An increase in misfolded polyke-I) or noncovalent (type II) assembly of catalytic domains.
tides is seen in ketoreductase-deficient mutants of someBoth fatty acid and polyketide biosynthesis proceed via
synthases (Kunnari et al., 1999), and in extreme casesthe iterative decarboxylative condensation of (normally)
the minimal system produces no polyketide in the ab-malonyl or methyl-malonyl extender units to a starter
sence of the KR (Hertweck et al., 2004).unit, usually acetate. Polyketide synthases achieve their
To date, the structures of five type II aromatic PKSstructural diversity by selecting primer and extension
components have been solved. These are the X-ray
structures of the unusual priming -ketosynthase (a*Correspondence: matt.crump@bristol.ac.uk (M.P.C.); a.t.hadfield@
bristol.ac.uk (A.T.H.) KASIII homolog) from the R1128 polyketide biosynthetic
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pathway (Pan et al., 2002), the ActVA-Orf6 monoxygen-
ase involved in actinorhodin biosynthesis (Sciara et al.,
2003), and NMR solution structures of three ACPs: act
(Crump et al., 1997), otc (oxytetracycline), (Findlow et
al., 2003) and fren (frenolicin) (Li et al., 2003). There is
currently no three-dimensional structure for a polyketide
type II ketoreductase; however, the act KR is a member
of the short-chain dehydrogenase/reductase evolution-
ary family (SDR) of NADP(H)-dependent enzymes (Figure
2) (Jornvall et al., 1995; Kallberg et al., 2002; Oppermann
et al., 2001, 2003). Over 2000 primary SDR sequences
across varied genomes have been reported, and over
20 related crystal structures have been solved (Opper-
mann et al., 2003). The sequence homology between
individual enzymes is low (10%–30%), but they all pos-
sess a high degree of three-dimensional structural ho-
mology, based around an / Rossman fold. The most
closely related sequences to the act PKS KR are those
of fatty acid ketoreductase enzymes. These reduce the
-keto carbonyl of the -ketoacyl-ACP in the first reduc-
tive step of de novo fatty acid biosynthesis (Cohen-
Gonsaud et al., 2002; Fisher et al., 2000; Price et al.,
2001, 2004). A conserved triad consisting of serine, tyro-
sine, and lysine has been identified in the active site
of the SDR enzymes (Ghosh et al., 1994). A catalytic
mechanism of reduction is thought to proceed via a
hydride transfer from the NADPH followed by proton
donation from the nearby phenolic hydroxyl group of
the tyrosine (Jornvall et al., 1995). The Lys may lower
the pKa of the Tyr-OH and promote proton transfer, while
the Ser group can interact with the keto group of the
substrate.
Here, we report the first three-dimensional structure
of a type II polyketide reductase, act KR, from the
S. coelicolor actinorhodin pathway. The crystal struc-
ture, which has been determined in an NADP-bound
form at 2.5 A˚ resolution, reveals a tetrameric arrange-
ment of subunits. The two subunits in the crystallo-
graphic asymmetric unit have different conformations.
Crystal contacts and population of the active site with
polar solvent in one of the two subunits provide clues
to the mechanism of ACP and substrate binding. This
structure provides insights into the possible interaction
of the act KR and the ACP and the nascent polyketide
chain.
Figure 1. Polyketides Produced by the Minimal and KR-Supple-
mented PKS Complex, Biosynthesis, and Identification
(A) HPLC analysis of in vitro activity of ketoreductase in the extended
Results and Discussionminimal PKS. The solid trace shows the extract from the act minimal
PKS system showing production of SEK4 and SEK4b. The dotted
trace shows the extract of the act minimal PKS plus ketoreductase Activity of the His6-Tagged Act KR
where mutactin is the major product. Typically, the assay contained To test whether the act KR was active, this enzyme was
ACP (50 M), KS/CLF (1 M), KR (10 M), DTT (0.1 mM), EDTA (2 reconstituted with the act minimal PKS in vitro using
mM), malonyl CoA (1 mM), NADPH (2 mM), and 10% glycerol, buf-
the method described by Zawada et al. (Zawada andfered by 0.1 mM KH2PO4 at pH 7.3, in a final volume of 100 l.
Khosla, 1999) (Figure 1). The appearance of a new peakPolyketide metabolites were extracted with ethyl acetate, freeze
dried, and analyzed by HPLC using methanol as the solvent. characteristic of mutactin and the loss of signal from
(B) Putative biosynthetic scheme for the early steps of actinorhodin SEK4 and SEK4b indicated that the enzyme was active
biosynthesis. Eight malonyl CoA molecules are used in the assembly in the extended minimal complex. The monomeric mo-
of a 16 carbon atom backbone, which gives a mixture of SEK4 and
lecular weight of the act KR is 27,265 Da for a 261 residueSEK4b when catalyzed by the miminal PKS alone. Addition of the
gene product. The enzyme that was crystallized in thisKR leads to increased fidelity of the C7-C12 ring closure and produc-
study had the N-terminal his tag intact and was thereforetion of mutactin.
281 residues long with an expected molecular mass of
29,291 Da.
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Figure 2. Sequence Alignment of the Act KR with Other Enzymes in the SDR Family
Sequence-based multiple alignment of SDR sequences. Four representative PKS type II KRs are shown (from a pileup of 28) from S. coelicolor
(act), S violaceoruber (gra), S. cinnamonensis (mon), and S. roseofulvus (fren). Residues that are 95% conserved are shaded with red for
the NADP binding site, green for the active site, blue for the outside surface/tetramer interface, and magenta for structural roles. If the
residue is conserved in the most closely related FAS and other reductases, it is also shaded with the same color code. The additional
sequences are E. coli -keto acyl-ACP ketoreductase (labeled E. coli), B. Napus -keto acyl-ACP reductase (B. napus), Tropinone reductase
from Datura stramonium (Trop II), trihydroxynapthalene reductase from Magnaporthe grisea (TriHNR), and tetrahydroxynapthalene reductase
from Magnaporthe grisea (TetHNR). The sequence alignment was produced using ClustalX.
Quaternary Structure are arranged in a Rossman fold with a parallel, twisted
seven-stranded  sheet flanked on one side by helicesIn the crystal, the oligomeric arrangement is clearly a
tetramer made up from a dimer of dimers, which there- 1, 2, and 8 and by helices 3, 4, and 5 on the
other. Helices 6 and 7 lie above the sheet, with thefore has three perpendicular 2-fold symmetry axes (2,2,2
symmetry). A dimer lies in each asymmetric unit, and axis of helix 6 parallel to the  strands and helix 7
lying perpendicularly. Helices 6 and 7 form a helix-one of the tetrameric 2-fold axes coincides with a crys-
tallographic 2-fold axis (Figure 3A). There are two types turn-helix motif on the top edge of the core of the protein.
Dinucleotide Binding Siteof dimer interface as described for the structure of
-ketoacyl-ACP reductase from E. coli (Price et al., NADPwas clearly visible in the original phase improved
electron density maps. It is bound in an extended confor-2001). The model for subunit A comprises residues 3 to
261, while subunit B includes residues6 to 261 (except mation at the C-terminal ends of the strands in the Ross-
mann fold in a manner often described for dinucleotidefor residues 203 to 209, where there is no visible electron
density). Residues 6 to 0 are part of the N-terminal his binding enzymes (Figures 3C and 3D) (Oppermann et
al., 2003). At the N terminus of helix 1, the characteris-tag and are numbered to allow the N-terminal methio-
nine to be designated as residue 1. tic GxGxxG motif observed in the general NAD binding
family is replaced in the SDR family by the sequenceSubunit Structure
The ketoreductase has the overall short-chain SDR fold 13GA/GTSGIG19, which is conserved in many type II PKS
KRs (Figure 2). Arg38 (which is conserved in type IIwith a single subunit dimension of 40  35  60 A˚
(Figures 3B and 3C). The  helices and the  strands PKSs) stacks against the adenine and also makes direct
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Figure 3. Three-Dimensional Structure of the Act KR
(A) Tetrameric arrangement of ketorductase drawn with helices and strands shown in cartoon style. The A subunit is drawn in magenta. The
B subunit is drawn in green. NADP is shown in gold in each of the four subunits.
(B) Topology diagram.
(C) Cartoon representation of a single subunit with NADP and the catalytic triad shown in bond representation.
(D) Space-filling representation of the active site and surrounding regions. Conserved residues of type II aromatic PKS reductases are colored
according to the following: red, NADP binding site; green, active site; blue, surface residues. The other three subunits in the tetramer are
shown in cartoon representation colored green (B subunit), magenta (C subunit), and dark green (D subunit).
hydrogen bonds with the 2 phosphate (front of Figure tion of the nicotinamide group is well defined. The amide
carbonyl hydrogen bonds with the main-chain nitrogen3B, bottom of Figure 3D). The pyrophosphate is lying at
the N-terminal end of helix 1 and helix 6. The pyro- of Val190, and the amide nitrogen hydrogen bonds with
the side-chain OH of Thr192 as well as an oxygen fromphosphate group forms one main-chain interaction
(Ile18, N), one side-chain interaction (Ser16 OH), and an its own phosphate. The pyridine ring of the nicotinamide
base stacks against Pro187, which is part of the PGinteraction with the amide nitrogen of its own nicotin-
amide group. Both of the 3,4 sugar hydroxyls interact motif that is highly conserved across the SDR family.
Substrate Binding Sitewith residue Lys161, which is a conserved residue in
the SDR family and part of the catalytic triad along with By analogy with other SDR structures, the substrate
binding site lies at the carboxyl ends of the  strandsSer144 and Tyr157. The 3OH also hydrogen bonds with
the main chain carbonyl oxygen of Asn90. The orienta- in the Rossmann fold, above the NADP cofactor and
Act Ketoreductase
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Figure 4. Open and Closed Forms and Active Site Configuration of the Act KR Subunit
(A) Superposition of subunit A (Open, magenta) and subunit B (Closed, green) in cartoon representation shown looking along the central 
sheet. Side chains shown in gray superimpose in the two active sites. Side chains shown in green are specific to the B subunit active site
(Met B194), and side chains shown in magenta are specific to the A subunit active site (Met A194, S2, S3, S4).
(B) Stereoview of active site of subunit A. Helices 4 and 5 are show in cartoon representation; catalytic residues are shown in bonds
representation, with bonds shown as gray lines where atoms lie within 3.4 A˚. Electron density is shown within 7 A˚ of Tyr157 from a difference
map calculated by omitting Tyr157 (from subunits A and B), S2, and S3.
(C) A similar view of the active site in subunit B.
toward the C-terminal end of the subunit (Figures 3B nounced. This subdomain is 10 residues longer than
the analogous structure in the FAS ketoreductasesand 3C). This is well defined in the electron density of
both subunits apart from the loop linking helix 6 to (Fisher et al., 2000; Price et al., 2001). There are three
conserved residues among the type II polyketide KRshelix 7, which was too disordered to model in subunit
B (residues B203–B209). The substrate binding pocket in this subdomain. Arg199 forms a salt bridge with
Glu191 on the outside face of the subdomain and pre-is formed by the C termini of strands 4, 5, and 6,
the N terminus of helix 5 on one side and the helix sumably plays a structural role. Val198 and Tyr202 point
into the active site. This side of the active site cleft is6-loop-helix 7 subdomain on the other (Figure 4A).
Despite the large size of the cavity, water is completely lined with a mixture of hydrophobic (e.g., Ile205, Ile217,
and Val198) and aromatic polar side chains (Tyr202,excluded. The C terminus of strand 4 forms the entrance
to the active site and has the sequence GR93PG95GG Tyr226, and Trp206). Two charged groups, His201 and
Arg220, are close to the cavity but do not point toward(Figure 3D), which is highly conserved in type II polyke-
tide ketoreductases (Figure 2). Ser144 is located at the the inside. An electrostatic surface map was calculated
with GRASP for the whole cavity, revealing that it isC terminus of strand 5 within the conserved sequence
ASTxGKQGV. Tyr157 and Lys161, the remaining resi- predominantly hydrophobic with strategically placed
polar side chains facing inwards. Stabilization of oligo-dues of the catalytic triad, are located at the N terminus
of helix 5. Adjacent to Ser144 is Thr145, whose hy- keto acids is best achieved under highly controlled con-
ditions where intra- and intermolecular aldol condensa-droxyl group points into the active site. On the opposite
side, helices 6 and 7 extend the classical NADP tions are avoided (Harris and Harris, 1986). Polyketide
stability is maximized in solvents of low dielectric con-binding fold and make the active site cleft more pro-
Structure
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stant where enolate ions are poorly stabilized and where on the six-membered ring (PDB code 2AE2, Yamashita
et al., 1999). Although it is not a polyketide, we proposethe environment is acid or base free. The predominantly
that this might mimic the positioning of the reduced six-hydrophobic cavity may therefore be a requirement for
membered ring of a C7-C12 cyclized polyketide interme-polyketide stabilization.
diate. The active site of TR-II was superimposed on the
act KR by aligning the C atoms. When this was done,
Comparison of A and B Subunits the reduced oxygen of 	-tropine and the oxygen of the
The Hinge Region formate S2 lie within 0.5 A˚ of each other, further sug-
When the A and B subunits are overlayed via the central gesting that this formate mimics the position of the C9
 sheet (see Experimental Procedures), the catalytic res- carbonyl. The other oxygen of formate S2 lies 3.4 A˚ from
idues superimpose closely. The major structural differ- Thr145. Formate S3 lies above Tyr157 with an oxygen
atom 3.4 A˚ from the amide nitrogen of residue Gly95ences between the two subunits are limited to one side
(Figure 4B), and formate S4 hydrogen bonds to the phe-of the substrate binding site. In subunit A (open), helices
nolic hydroxyl of Tyr226. Gly95, Thr145, and Tyr2266 and 7 are rotated 19
 as a rigid body compared
(shown in gray in Figures 4A and 4C) are 100% con-to the B subunit (closed) (Figure 4A), with conserved
served in a sequence alignment of 28 aromatic type IIresidues Pro193 at the N terminus of 6 and Pro222 at
reductases (data not shown). In contrast, there are nothe C terminus of 7 acting as a hinge. This rotation has
water molecules or other solvent molecules (e.g., for-the effect of opening the active site cleft in the A subunit
mate) in the closed B subunit active site, and no unex-compared to the conformation in subunit B. Methionine
plained electron density features above 3  in the differ-194 at the entrance of the active site is in a compact
ence electron density maps (Figure 4C).rotamer in the open A subunit, whereas it adopts a more
Crystal Contacts: A Novel Mechanismextended conformation in the closed B subunit. The
of Active Site Openingextended conformation in the closed B subunit effec-
In the act KR, cofactor binding does not appear to drivetively restricts access to the active site.
opening of the A subunit, since both open and closedDespite the variability of the size of this subdomain
active sites have bound NADP. In fact, the arrangementamong different SDRs, the ability of the helix 6 and
around the active site in the closed B subunit of the acthelix 7 to form a hinge region that opens up the active
KR is very similar to the NADP complex structure insite appears to be quite common. These hinge regions/
the FAS -keto acyl carrier protein reductase (PDB IDbinding loops are always on the outer surface of the
code 1EDO; Fisher et al., 2000). Examination of the crys-homotetramer, where conformational changes will not
tal structure suggests that, in the case of act KR, theinterfere with the association of the subunits. Movement
opening is driven by a crystal contact with a crystal-of the loops outward to increase binding cavity space
symmetry-related B subunit (B) that impinges on theand flexibility may allow different sized substrates to
NADP binding region and the active site of subunit Aenter the binding site and yet be retained in a solvent-
(Figure 5A). The neighboring B subunit has two four-free environment (Rozwarski et al., 1999). Previously,
residue N-terminal helices, helix a in the N-terminal hiscomparisons of two FAS -keto acyl carrier protein re-
tag (residues 4 to 1) and b (residues 1–4) (shown
ductases suggested that the 6/7 subunit swings out
in green, Figure 5A). Helix a inserts between helix 6
to create an open form in response to the binding of
and strand 4 at the top of the active site of the A
NADP (Price et al., 2001, 2004). subunit. This turn of helix packs against Met 194, pre-
Population of the Active Site with cluding the more extended conformation of this side
Formate Molecules chain observed in the B subunit. The turn b binds along
The enzyme was crystallized in 4 M sodium formate. the adenine of the NADP, and the edge of the central
Three formate molecules are bound in the active site  sheet of the B subunit lies along the top of the bound
of the open A subunit. These formates may indicate nicotinamide, with helix 2 and strand 3 forming the
favorable binding sites for the carbonyl oxygens of a majority of the contacts.
nascent polyketide chain. The S2 formate has one of its The equivalent N terminus of the A subunit is disor-
oxygens 3.4 A˚ from both the hydroxyl groups of the dered where it lies in a different crystallographic environ-
catalytic Ser144 and Tyr157 (Figures 4A and 4B). For- ment. No such crystal contact is seen in the active site
mate S2 may be positioning its carbonyl group at the of subunit B, suggesting that protein-protein interac-
same position as the C9 that is reduced in the polyketide tions are essential for active site opening. Such a mecha-
chain. Two analogous enzymes, tropinone reductase nism has not been previously observed or proposed for
I and II (TR-I and TR-II), are well-characterized SDR this class of enzyme. The overall organization of the
enzymes for which enzyme-substrate complexes are active site region in the open A subunit is very similar
available (Protein Data Bank [PDB] ID codes 1ac1 for to a tropinone reductase structure which was deter-
TR-I and 2ac1 for TR-II; Nakajima et al., 1998). Both mined in the presence of both a substrate analog and
reductases reduce the carbonyl group of their cyclized the cofactor NADP (2AE2) (Yamashita et al., 1999). For
substrate tropinone, but yield an -hydroxyl group with the act KR, therefore, both the protein-protein interac-
a different diastereomeric configuration. In both cases, tions and the formate binding may be mimicking a sub-
the Pro-(S ) hydride is delivered from NADPH, and the strate-bound complex. Crystal contacts have been ob-
orientation of tropinone (and hence the face that is pre- served at the 6/7 subunit of the open NADP-bound
sented to the NADPH) governs the diastereoselectivity. form of E. coli FAS -keto acyl carrier protein reductase
TR-II performs a stereoselective reduction of tropinone (Price et al., 2004), but the change in conformation ob-
served was attributed to NADP binding.to give 	-tropine, where the hydroxyl group is equatorial
Act Ketoreductase
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Figure 5. ACP Binding to the Act KR
(A) Location of crystal contacts from an adja-
cent B subunit (cartoon representation, shown
in green), with location of N termini of helices
1, 2, and 3 in ACP shown in blue. Top half
of A subunit shown in magenta in cartoon
representation.
(B) Cartoon of ACP carrying a polyketide sub-
strate (not to scale).
(C) View of model of ACP docking. ACP is
shown in blue cartoon representation, with
E47, the phosphopantetheine chain, and a
model polyketide substrate shown in ball and
stick representation. Subunit A is shown in
magenta, with important active site residues
shown in ball-and-stick representation.
(D) Close-up of interface between E47 from
helix 2 in ACP and subunit A.
Modeling of ACP Binding in a U-turn conformation, with the thioester bond point-
ing back out of the major portal toward the proposedThe polyketide substrate for the KR is presented to the
enzyme by ACP (Figure 5B). We therefore looked for ACP binding site.
Further inspection of the ACP docking model showedpossible interaction sites on the structure we have deter-
mined. The turn of helix a from the B subunit includes that Glu47 of the ACP helix 2 was located in a positively
charged pocket made up from the terminal groups ofa serine residue that could be mimicking Ser42 of helix
2 of ACP. This residue is known to carry the nascent three arginines, Arg38, Arg65, and Arg93, and lined by
the adenine base of NADP (Figure 5D). In the crystalpolyketide chain via a phosphopantetheine linker. NMR
studies of the E. coli ACP binding to the FAS KR, cocrys- structure, Glu56 from the crystallographically related B
subunit lies in a similar position to Glu47 in the modeltallization of the B. subtilis phosphopantetheinyl trans-
ferase-ACP complex, and mutations of ACP have all of ACP, making a hydrogen bond with Arg38. There are
structurally similar residues which are conserved in theimplicated the helix2-loop-helix3 of ACP in protein-pro-
tein interactions (Parris et al., 2000; Roujeinikova et al., FAS KRs (Fisher et al., 2000; Price et al., 2001; Zhang
et al., 2001).2002; Worsham et al., 2003; Zhang et al., 2001, 2003).
The positioning of the B subunit close to the major It has been shown recently that mutation of two con-
served Arg residues (Arg172 and Arg129) in the E. coliportal may therefore suggest a possible position for this
motif in the act KR-ACP interaction. The N terminus of KR (FabG) abrogates fatty acid biosynthesis (Zhang et
al., 2003). The authors proposed that these residues arehelix 2 in the act ACP structure was manually overlayed
with a of subunit B, helix 1 of ACP with b of subunit essential for ACP binding to the FAS KR. They are not,
however, conserved in PKS KRs, their closest counter-B, and helix 3 with helix 2 (Figure 5A). The model
positions helix 2 from ACP parallel with the top of the parts being Arg177 and Arg134, which lie surprisingly
far from the active site on the opposite side of the SDR sheet and the NADP of subunit A (Figure 5C). The
docked structure provided good steric complementarity fold. Arg134 lies close to a dimer interface and is in-
volved in a salt bridge with Glu85 from the same subunitbetween the ACP and subunit A and positions Ser 42
at the end of the active site ready to deliver substrate. on the surface of the molecule. In addition, Arg177
makes a hydrogen bond with the carbonyl oxygen ofEvidence for ACP binding at the major portal also comes
from the structure of the Mycobacterium tuberculosis the conserved proline at the end of helix 7, which we
postulate to be a hinge allowing the opening of the activeenoyl-ACP reductase, InhA in complex with NAD, and
a C16 substrate (trans-2-hexadecenoyl-(N-acetylcyste- site cleft. Mutations in these residues might be expected
to affect tetramerization and possibly mobility of theamine)-thioester) (Rozwarski et al., 1999). The C16 binds
Structure
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Figure 6. Modeling the Bound Polyketide
Substrate within the Act KR Active Site
(A) Space-filling representation of the ACP-
bound octaketide in the KR active site. The
KR surface is shown in magenta, the NADP
is shown in yellow, the phosphopantetheine
side arm is shown in marine blue, formates
S2–4 are shown in cyan, and the polyketide
is shown in dark blue. The first C7–C12 cycli-
zation has been made in this model, and the
(R ) stereochemistry at C9 was assumed.
(B) Identical to (A), except that no C7–C12
cyclization has been made.
(C) Stereoview of close-up of the cyclized
polyketide substrate modeled into the active
site, with oxygen substituents interacting in
similar positions to the observed formates.
(D) Cartoon of the approach and binding of
ACP. In the absence of ACP (i), the active site
is closed with water excluded. A positively
charged patch is presented on the surface of
the KR (blue), which is complementary to a
negatively charged patch that lies on helix 2
of ACP (red). (ii) ACP docks, via steric and
charge complementarity, the active site is
opened, and the unstable substrate is ex-
truded into the active site.
6-7 unit and could therefore affect ACP binding and stereochemistry. The presence of Trp141 is classed as
“A”-type, while the presence of an Leu-Asp-Asp motifenzyme activity.
is classed as “B”-type (Caffrey, 2003; Ostergaard et al.,
2002; Reid et al., 2003), and both give opposite stereo-Possible Positioning of the Substrate
chemistry. However, sequence comparisons indicatewithin the Active Site
that no similar motif exists in the type II KRs, precludingThe presence of formate in the open active site of sub-
this type of prediction. It is also possible that the stereo-unit A suggests that this subunit is a pseudo-substrate
chemistry of the hydroxyl group in mutactin could indi-complex, where one or other of the formate oxygen
cate the correct orientation of the polyketide, but to dateatoms mimics a carbonyl group of the bound oligoketo-
the absolute configuration of mutactin has not beenacid. Using the information provided by the positioning
determined (Zhang et al., 1990).of the formate molecules, we constructed a model of
We have instead drawn comparisons with the Wailu-the putative polyketide intermediate bound to the KR
pemycin A biosynthetic pathway, which proceeds(Figures 6A–6C). The unreduced octaketide with a single
through a similar C7-C12 cyclization and is reduced atcondensation between C7–C12 was used as the docked
C9 by EntD, a homolog of KR. In this case, the absoluteintermediate (Figure 5B). Using the docked position of
stereochemistry has been determined as R (Sitachittathe ACP derived by crystal contacts, the phosphopan-
et al., 1996; Xiang et al., 2002). We therefore restrictedtetheine cofactor was built and the polyketide was
the orientation of the ring in the docked polyketide suchadded by a thioester linkage to its end. There are, how-
that reduction of the C9 carbonyl generated the (R )-ever, two possible orientations of the cyclized polyketide
configuration.that will give alternate stereochemistry for the reduced
With this limitation, the polyketide was positioned inalcohol. For the type I modular PKSs, the KRs have a
recognizable motif that enables the prediction of alcohol the cavity so that the C9 carbonyl was close to the
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formate (S2) and was interacting with Thr145, Tyr157, ity. The substrate is restrained in a favorable conforma-
tion by interactions between its carbonyl oxygens andand Ser144. The phosphopantetheine-bound polyketide
chain now forms a hairpin turn where C1 lies next to with a limited number of conserved polar groups ar-
ranged around the hydrophobic cavity. An attractivehelix 6 and helix 7, with the C1–C9 section of the
polyketide adjacent to the minor portal. The free C12– feature of this model of ACP binding is that the essential
features of the binding site are preserved in a range ofC16 end of the polyketide projects back toward the
major portal and the ACP entry point. The orientation proteins that bind NADP(H). This is necessary to explain
the promiscuity of different ACPs that are to be able toof the polyketide now positions the C1 carbonyl close
to formate S4 and within hydrogen bonding distance of interact with reductases from different synthetic path-
ways, including fatty acid biosynthesis.the Tyr226 (Figures 6A and 6C). The terminal oxygen
attached to C15 in the model lies within hydrogen bond-
Experimental Proceduresing distance of the main chain of the conserved Gly95,
and is close to the oxygen in formate S3. Restrained
Expression, Purification, and Crystallizationminimization was then applied to remove poor geometry
The expression, purification, and crystallization of the act KR pro-
and van der Waals’ contacts and bring the C1(O), C9(O), ceeded as described previosuly (Teartasin et al., 2004) Briefly, re-
and C15(O) of the polyketide as close as possible to combinant actIII was expressed in E. coli BL21(DE3) in the pET15b
formate oxygens. It was found that the cavity allowed vector (Novagen) with an N-terminal his-tag. The fully active enzyme
was purified in a single step by affinity chromatography on Ni2ample space for the phosphopantetheine arm and
column (Novagen). Crystals were grown using 5 mg/ml protein inbound intermediate, and each of the three formate bind-
25 mM phosphate buffer at pH 8 with 10% glycerol and 2.5 mMing sites could be utilized by the polyketide to within
NADP. Crystals were obtained at 18
C by hanging drop vapor
less than 0.5 A˚. A model was also built in the same way diffusion against wells containing 4.0–4.4 M sodium formate. The
using a linear octaketide. In this model, the C9 oxygen crystals belong to the space group P3221 with cell dimensions a 
interacts with Tyr157 and Ser144, but the additional flex- b  103.9 c  123.1     90.0   120.0. Diffraction data,
100% complete to 2.5 A˚ resolution, were collected at 100 K usingibility of the linear chain allows Thr145 to interact with
synchrotron radiation at station 14.2 at the Daresbury Laboratorythe C7 oxygen (Figure 6B). The other interactions are
SRS (25,369 reflections from 20–2.5 A˚) and reduced using HKL-2000similar to those seen with the cyclic intermediate.
(HKL Industries, plc).
In order to make a comparison with other known KR-
substrate complexes, we superimposed the active site Structure Determination and Refinement
of the tropinone-II-	-tropine complex onto the act KR- The structure was solved by molecular replacement with Amore
polyketide complex. As expected, the carbonyl of 	-tro- (CCP4, 1994) using the protein coordinates of Brassica napus -keto
acyl carrier protein reductase (PDB ID code 1EDO; Fisher et al.,pine is positioned very similarly with the C9 carbonyl of
2000). Phase improvement, taking advantage of the 2-fold NCS,the polyketide. The C1–C7 portion of the polyketide
was performed using Resolve. The starting model was built usingchain forces the ring to twist compared to tropine, but
a combination of the molecular replacement model and the PDB
the cavity allows it to accommodate this, and the car- file that was automatically built within Resolve. The structure was
bonyl is still positioned suitably for hydride transfer. built using O (Jones et al., 1991) and refined in Refmac, with 5% of
The hydrogen bonds the polyketide makes within the the data set aside as a free set. Solvent sites were identified using
CCP4 programs (CCP4, 1994). The secondary structure is formedactive site are all with conserved residues, as is ob-
from eight  helices (46%), seven  strands (14.7%), and a seriesserved for the formates in the crystal structure. The side-
of turns, loops, and short 310 helices (4.6%). The final model com-chain hydroxyls of residues Tyr157, Ser144, Thr145, and
prises 3988 atoms in 2 protein chains, 2 molecules of NADP, 9
Y226 are the major polar side chains that point into the formate molecules, and 44 water molecules, and has an Rcryst 
cavity and may play a potential role in polyketide chain 18.9% (21%) (Rfree  22.2% [26.4%]). Overall, the model shows good
recognition/stabilization. The synthesis of suitable poly- stereochemistry. All nonglycine and nonproline residues lie within
the allowed regions of the Ramachandran plot, with 91.1% lying inketide mimics should allow us to cocrystallize the act-
the most favored regions and 8.9% in the additional allowed regions.KR with these substrates and examine the specificity of
The root-mean-square deviation for bond lengths is 0.012 A˚ and forthe active site more closely.
angles is 1.5
.
The crystal structures of related short-chain dehydrogenases
were overlaid on polyketide ketoreductase for comparison. Because
Conclusions of conformational variability in the active site, which was one prop-
erty we wanted to compare, the overlays were performed by super-
imposing the residues in the  strands of the Rossmann fold usingIn summary, the structure suggests a model where
“lsq_exp” in O (Jones et al., 1991). The rms deviation between theNADPH binds, which stabilizes the tetramer (Teartasin
positions of the C carbons for these residues was around 0.5 A˚2et al., 2004). In this tetrameric state, the cofactor is in
in each case for the PKS and FAS ketoreductases and around 0.8 A˚2
place and the enzyme is primed (Figure 6D). While the for the FAS enoyl reductase.
catalytic residues are correctly positioned, the substrate
binding site remains closed, with water excluded. ACP Molecular Modeling
recognizes a positive patch on the surface of the ketore- Putative polyketide substrates were modeled into the active site
using the DISCOVER forcefield and InsightII (Accelrys). Using theductase, which is only preformed when the cofactor is
ACP-ketoreductase model derived from the crystal contacts, thebound. In this way, the substrate is only delivered when
phosphopantetheine arm and C16 polyketide chain was covalentlythe enzyme is ready for catalysis. Binding of the ACP
linked to the ACP Ser 42 and extruded into the active site by manualalong the top of the nicotinamide triggers a conforma-
manipulation of the chain. Two different C16 chains were consid-
tional change in the active site of the enzyme, opening ered, the first with the C7-C12 cyclization and the second a linear
the substrate binding cleft to allow insertion of the reac- polyketide. On the premise that the bound formate molecules may
indicate favorable positions for the polyketide carbonyl groups, sev-tive substrate into the predominantly hydrophobic cav-
Structure
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eral distance restraints were added to the minimizations of the sub- Hertweck, C., Xiang, L., Kalaitzis, J.A., Cheng, Q., Palzer, M., and
Moore, B.S. (2004). Context-dependent behavior of the enterocinstrate. These attempted to force the polyketide carbonyls to the
same point in space as the formate oxygens. For the ring closed interative polyketide synthase: a new model for ketoreduction.
Chem. Biol. 11, 461–468.polyketide, a restraint to mimic the positioning of S4 was added
between the C1(O) of the polyketide (numbering as in Figure 6) Hopwood, D.A. (1990). Molecular-genetics of polyketides and its
and Tyr226 hydroxyl group. The C9(O) was restrained with multiple comparison to fatty- acid biosynthesis. Annu. Rev. Genet. 24, 37–66.
restraints to Thr145, Ser144, and Tyr157, and the C15(O) with a
Hopwood, D.A. (1997). Genetic contributions to understanding poly-restraint to Gly95 NH. For the linear polyketide, C9(O) had no re-
ketide synthases. Chem. Rev. 97, 2465–2497.straint to Thr145 hydroxyl, and instead a restraint was included for
Jones, T.A., Zou, J.-Y., Cowan, S.W., and Kjeldgaard, M. (1991).C7(O). All atoms of the tetramer were fixed, and the polyketide was
Improved methods for building protein models in electron-densityminimized in the open form active site of the A subunit. Steepest
maps and the location of errors in these models. Acta Crystallogr.descents minimization was performed until the RMS derivative for
A 47, 110–119.the energy change converged.
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